October 28, 2025 – Envision Pharma Group

News and views:

October 28, 2025

New

Building an AI-enabled medical insights journey with a top 20 pharma client

AI, Medical, Publications, Strategic Consulting, Technology

Oct. 18, 2024

Streamlining insights from 5 months to 2 weeks across 100,000+ records and 50+ countries....

Game on: The high stakes and growing pains of bringing cell and gene therapies to market

Cell and Gene Therapies, Commercialization, Medical, Strategic Consulting, Two Labs

Oct. 02, 2024

From science to market: trends and strategies for successful cell and gene therapy commercialisation...

Publication Bias: The hidden threat to systemic literature reviews

Medical, Strategic Consulting, Systemic Literature Reviews

Sep. 26, 2024

Discover how to address publications bias to improve patinet outcomes and healthcare decisions...

Envision Pharma Group launches EnvisionOne Insights

Analytics, Compliance, Data, Medical, Publications, Technology

Sep. 11, 2024

AI-powered real-world evidence: Strategically enhancing value and access

AI, Market Access, Medical, Real World Evidence, Strategic Consulting

Aug. 22, 2024

Envision Pharma Group (Envision) has announced today the appointment of Alistair Macdonald to the Envision Board of Directors.

Executive Leadership

May. 08, 2024

Envision Pharma Group (Envision) has appointed Alice Choi as President, Envision Medical Communications (EMC) and member of its Executive Leadership Team.

Executive Leadership

Jan. 16, 2024